DCOY logo

DCOY Decoy Therapeutics Inc.

NASDAQ Capital Market · Biotechnology · Healthcare

$0.91
-0.07 (-7.20%)

Based in Cambridge, Massachusetts, Decoy Therapeutics Inc. is an early-stage biotechnology firm dedicated to tackling critical unmet medical needs. The company employs cutting-edge machine learning and AI technologies, alongside accelerated synthesis methods, to swiftly design, engineer, and manufacture innovative peptide conjugate drug candidates.

Market Cap: $481.4Kdecoytx.com

Price

No data yet.

Social Signal Score

48
5d
—
30d
50
2 mentions
—
60d
48
3 mentions
—
90d
47
6 mentions
—
news: 6

Analyst Ratings

1 analyst
Buyconsensus
Strong Buy 0Buy 1Hold 0Sell 0Strong Sell 0

Revenue

$307.4K+2.85%
$-1.84M$-733.8K$372.5K$1.48M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-57.95
$-57.95–$-57.95
1 analysts
FY2026
$-11.34
$-11.34–$-11.34
1 analysts
FY2027
$-9.46
$-9.46–$-9.46
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Frederick E. Pierce
Sector
Healthcare
Industry
Biotechnology
Employees
11
Beta
0.58
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
-21.79
decoytx.com